The present invention provides stable liquid pharmaceutical formulation of pemetrexed or pharmaceutically acceptable salts thereof comprises at least one stabilizing agent selected from the group consisting of sodium formaldehyde sulfoxylate, EDTA and derivatives and mixtures thereof.